• Puerarin Activates NO Signaling in Dental Follicle Cells

  2026-08-08

  The reference study identifies nitric oxide signaling as a mechanistic contributor to puerarin-induced osteogenic differentiation in rat dental follicle cells. By combining osteogenic markers with pharmacological NOS inhibition, it links puerarin treatment to the NO–cGMP–SGC/PKG-1 axis and provides a useful framework for periodontal regeneration research.

• Calcium Channels in Cardiac Vagal Neuron Activation

  2026-08-07

  Wang, Irnaten, and Mendelowitz used whole-cell patch-clamp recordings and selective calcium-channel antagonists to show that nicotine activates cardiac vagal neurons through agatoxin-IVA-sensitive voltage-dependent calcium channels. The study separates presynaptic facilitation of glutamatergic release from the postsynaptic inward current, providing a pharmacological framework for analyzing nicotinic control of cardiac autonomic circuits.

• Itraconazole: Triazole Antifungal Agent for Candida Biofilm

  2026-08-07

  Itraconazole (APExBIO SKU B2104) equips researchers with a potent, multi-mechanistic triazole antifungal agent for dissecting biofilm resistance and autophagy in pathogenic Candida. This guide delivers applied protocols, troubleshooting tips, and advanced insights on leveraging Itraconazole for robust, reproducible in vitro and in vivo antifungal workflows.

• DAF-2 Diacetate: Precision Live-Cell Nitric Oxide Imaging Wo

  2026-08-06

  DAF-2 diacetate enables ultra-sensitive, quantitative detection of nitric oxide in live-cell, in vitro, and in vivo models. Its robust cell-permeable chemistry supports advanced NO signaling pathway studies, with proven success in dissecting plant nodule senescence and immune mechanisms.

• Rapid Microwave Heating Preserves Lactoferrin Structure and

  2026-08-06

  This study demonstrates that the rapid heating rate of microwave (MW) processing, rather than dielectric effects, is key to preserving the structural integrity and bioactivity of lactoferrin during dairy pasteurization. These findings inform optimization of industrial MW pasteurization to maximize the retention of functional proteins in dairy products.

• Cimetidine’s Distinct Role in H2R Signaling and High-Through

  2026-08-05

  Explore how Cimetidine, a histamine-2 receptor antagonist, uniquely advances research into H2 receptor signaling and blood-brain barrier models. This article offers a deep dive into its mechanistic advantages and how it redefines assay design in cancer and CNS drug discovery.

• Cholecystokinin Octapeptide Antagonizes Electroacupuncture A

  2026-08-05

  This study reveals that cholecystokinin octapeptide (CCK-8) dose-dependently counteracts electroacupuncture (EA) analgesia in rats, implicating endogenous CCK-8 as a mediator of EA tolerance. The findings clarify the peptide's antagonistic role in opioid signaling pathways and provide a framework for exploring CCK-8's broader neuromodulatory functions.

• Capsazepine: Advanced Insights into TRPV1 Antagonism and Pai

  2026-08-04

  Explore the unique role of Capsazepine as a TRPV1 ion channel antagonist in pain mechanism research. This article delivers an in-depth, comparative analysis of Capsazepine’s mechanistic utility and its advantages for translational studies on nociception and apoptosis.

• Pam3CSK4 in Translational Immunology: Precision TLR1/2 Agoni

  2026-08-04

  Explore how Pam3CSK4, a potent TLR1/2 agonist, is advancing translational immunology by enabling targeted immune cell activation and nuanced control of inflammatory responses. This article uniquely examines the intersection of TLR signaling, neuro-immune modulation, and experimental design, offering insights beyond existing guides.

• 2-NBDG in Glucose Metabolism Assays: Protocols & Innovations

  2026-08-03

  Harnessing 2-NBDG enables high-sensitivity, real-time analysis of cellular glucose uptake across cancer, metabolic disease, and neuroscience models. This guide integrates the latest protocol enhancements and troubleshooting strategies—rooted in leading research and practical lab experience—to elevate your glucose metabolism studies.

• Alda 1: ALDH2 Activator Workflows for Cardiac and Dermatitis

  2026-08-03

  Alda 1 is a powerful ALDH2 activator that enables advanced cardiac ischemia and radiation dermatitis models, uniquely restoring both wild-type and mutant enzymatic activity. This guide translates the latest research breakthroughs into actionable protocols, troubleshooting strategies, and high-impact workflow enhancements for translational researchers.

• Redefining Cell Viability Assays in Translational Research

  2026-08-02

  Explore how APExBIO's Resazurin Cell Viability Assay Kit empowers translational researchers to quantitatively dissect cell proliferation, link mechanistic insights to therapeutic innovation, and accelerate the path from molecular hypothesis to clinical impact. By integrating evidence from rare bone disease research and robust assay technology, this article provides actionable strategies for optimizing viability workflows and elevating experimental rigor in disease modeling and drug screening.

• Cholecystokinin Octapeptide Ammonium: Advanced Mechanistic I

  2026-08-01

  Explore the unique mechanistic landscape of Cholecystokinin octapeptide ammonium (CCK-8 ammonium) in preclinical neurobehavioral and immunological models. This article delivers a deep-dive into signaling pathways, protocol precision, and practical assay design, positioning CCK-8 ammonium as an indispensable tool for innovative research.

• Deracoxib: Selective COX-2 Inhibitor in Inflammation & Cance

  2026-07-31

  Deracoxib’s selectivity for COX-2 offers researchers a targeted approach for dissecting inflammation and tumor cell viability in canine models. This guide translates recent canine osteosarcoma evidence into stepwise protocols, troubleshooting, and advanced application strategies—demonstrating how APExBIO’s Deracoxib can streamline pain, inflammation, and cancer biology workflows.

• PA-824: Mechanistic Advances and Rational Regimen Design in

  2026-07-31

  Explore the scientific depth of PA-824, a leading bicyclic nitroimidazole derivative, focusing on its dual mechanism and how new insights into terminal oxidase inhibition reshape tuberculosis research. This article offers a fresh perspective on rational combination strategies and advanced applications.

16975 records 2/1132 page Previous Next 12345 下5页 Last page